Sjögren's syndrome (SS) and Epstein-Barr virus (EBV) reactivation

References

• Tsubota K, Nakamori K. Dry eye and video display terminal. N Engl J Med 1993; 328: 584
   PubMed Web of Science ®Google Scholar
• Bloch J J, Buchanan W E, Wohl M J, Burium J, Sjögren's J. syndrome: a clinical, pathogenical and serological study of sixty-two cases. Medicine 1965; 44: 187–231
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Nishido N, Okuda M. Cell-mediated immunity in Sjögren's syndrome. Allergy 1979; 28: 380–386
   Google Scholar
• Miyasaka N, Seaman W, Bankshi A, et al. Natural killing activity in Sjögren's syndrome. Arthr Rheumatol 1983; 26: 954–960
   PubMedGoogle Scholar
• Pepose J S, Akata R F, Pflugfelder S C, Voigt W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Ophthalmology 1990; 97: 1599–1605
   PubMed Web of Science ®Google Scholar
• Saito I, Servenius B, Comton T, Fox R I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and ti biopsies from patients with Sjögren's syndrome. J Exp Med 1989; 169: 2191–2198
   PubMed Web of Science ®Google Scholar
• Pflugfelder S C, Crouse C, Pereira I, Atherton S. Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients. Ophthalmology 1990; 97: 976–984
   PubMed Web of Science ®Google Scholar
• Tsubota K, Fujishima H, Toda I, et al. Detection of Epstein-Barr virus DNA in lacrimal gland of Sjögren's syndrome patients. Acta Soc Ophthalmol Jpn 1991; 95(Suppl)233
   Google Scholar
• Pflugfelder S C, Tseng S C, Pepose, et al. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology 1990; 97: 313–323
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Miyasaka N, Yamamoto K. Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome. Arthr Rheumatol 1988; 31: 1014–1021
   PubMedGoogle Scholar
• Miller-Barr G. Epstein virus. Virology, B Fields. Raven Press, New York 1985; 563–589
   Google Scholar
• Henle W, Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 1981; 4222–4225
   PubMedGoogle Scholar
• Alspaugh M A, Tan E M. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975; 55: 1067–1073
   PubMed Web of Science ®Google Scholar
• Tsubota K, Toda I, Yagi Y, et al. Three different types of dry eye syndrome. Cornea, in press
   Google Scholar
• Toda I, Fujishima H, Tsubota K. Ocular fatigue is a major symptom of dry eye. Acta Ophthalmol 1993; 71: 18–24
   Google Scholar
• Toda I, Tsubota K. Practical doublevital staining for ocular surface evaluation. Cornea 1993; 12: 295–298
   PubMedGoogle Scholar
• Ono M, Yoshino K, Ogawa Y, Tsubota K. Tear clearance rate in normal and dry eye patients. Invest Ophthalmol Vis Sci (suppl) 1991; 32: 1113
   Google Scholar
• Hamano T, Mitsunaga S, Kotan S, et al. Tear volume in relation to contact lens wear and age. Contact Lens Ass of Ophthalmol J 1990; 16: 57–61
   Google Scholar
• Tsubota K. The importance of the Schirmer test with nasal stimulation (letter). Am J Ophthalmol 1991; 111: 106–108
   PubMed Web of Science ®Google Scholar
• Fox R I, Robinson C A, Curd J G, Kozin F, Howell F, Sjögren's V. syndrome: proposed criteria for classification. Arthr Rheumatol 1986; 29: 577–585
   PubMed Web of Science ®Google Scholar
• Lockitch G, Halstead A C, Quigley G, MacCallum C. Age- and sex-specific pediatric intervals: Study design and method illustrated by measurement of serum proteins with the bearing LN nephelometer. Clin Chem 1988; 34: 1618–1621
   PubMedGoogle Scholar
• Senju O, Takagi Y, Uzawa R, et al. A new immuno quantitative method by latex aggregation-application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol 1986; 85: 99–103
   Google Scholar
• Henle W, Henle G, Horowitz C A. Infectious mononucleosis and Epstein-Barr virus-associated malignancies. Diagnostic Procedures for Viral, Rickettial and Chlamydial Infections, E H Lennette, N J Schmidt. American Public Health Association, Washington 1979; 441–470
   Google Scholar
• Whittingham S, McNeilage J, Mackay I R. Primary Sjögren's syndrome after infectious mononucleosis. Ann Int Med 1985; 102: 490–493
   PubMed Web of Science ®Google Scholar
• Frade R, Barel M, Ehlin-Henriksson B. gp 140, C3d receptor of human B lymphocytes is also Epstein-Barr virus receptor. Proc Natl Acad Sci USA 1985; 82: 1493–1499
   Google Scholar
• Sixbey J W, Vesterinen E H, Nedrud J G, Raab-Traub N, Walton L A, Pagano J S. Replication of Epstein-Barr virus in human epithelial cells infected in vitro (letter). Nature 1983; 306: 480–483
   PubMed Web of Science ®Google Scholar
• Sixbey J W, Nedrud J G, Raab-Traub N, Hanes R A, Pagano J S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310: 1225–1230
   PubMed Web of Science ®Google Scholar
• Sixbey J W, Yao Q. Immunoglobulin A-induced shift of Epstein-Barr virus ti tropism. Science 1992; 255: 1578–1580
   PubMed Web of Science ®Google Scholar
• Yamaoka K. The relationship between EBV and polyclonal B cell activation. Clin Immunol Jpn 1990; 22: 66–74
   Google Scholar
• Pflugfelder S C, Roussel T J, Culbertson W W. Primary Sjögren's syndrome after infectious mononucleosis. JAMA 1987; 257: 1049–1050
   PubMedGoogle Scholar
• Gaston J SH, Rowe M, Bacon P. Sjögren's syndrome after infection by Epstein-Barr virus. J Rheumatol 1990; 17: 558–561
   PubMedGoogle Scholar
• Fox R I, Pearson G, Vaughman J H. Detection of Epstein-Barr virus associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol 1989; 37: 3162–3168
   Google Scholar
• Roudier J. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DRB-I chain and Epstein-Barr virus glycoprotein gp 100. Proc Natl Acad Sci USA 1989; 86: 5104–5108
   PubMed Web of Science ®Google Scholar
• Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar